Explore the full directors' dealings record of 大幸薬品株式会社, a publicly traded company based in Japan. Shares are quoted on JP JP, under the oversight of EDINET (Japan FSA). Operating in the Healthcare sector, 大幸薬品株式会社 has recorded 6 reports. Market capitalisation: €12.8bn. The latest transaction was reported on 6 July 2023 — Holding update. Among the most active insiders: Nomura Securities Co.,Ltd.. The full history is accessible without an account.